Home > Boards > US OTC > Cannabis > Emerald Bioscience Inc. (EMBI)

In the event that the Company requires any

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
AntonChigurh Member Profile
 
Followed By 2
Posts 496
Boards Moderated 0
Alias Born 04/03/17
160x600 placeholder
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/7/2020 11:43:38 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/17/2020 6:17:53 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 8/13/2020 6:35:47 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 8/13/2020 5:20:24 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 5:17:59 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 8/13/2020 6:06:38 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2020 4:42:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 10:30:33 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/11/2020 2:53:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/11/2020 2:53:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/11/2020 2:52:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/11/2020 2:51:27 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/10/2020 4:43:45 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/7/2020 6:01:02 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2020 6:05:47 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/31/2020 12:03:31 PM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 7/31/2020 9:13:27 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 7/28/2020 4:35:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/22/2020 5:27:53 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/15/2020 12:25:29 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 5/8/2020 3:45:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2020 3:38:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2020 4:39:01 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 3/23/2020 6:08:42 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/23/2020 6:04:59 AM
AntonChigurh   Wednesday, 08/12/20 08:14:41 PM
Re: None
Post # of 5945 
In the event that the Company requires any information or testimony from Employee in connection with the matter entitled, Emerald Bioscience, Inc./Wendy Cunning, Case No. 9-3290-20-161 currently pending before OSHA, or any other claim that might be brought by Ms. Cunning, or any other claim made against the Company, or any claims made by the Company against persons or entities not party to this Agreement, Employee agrees to cooperate fully with and without cost to the Company, including: (a) appearing at any deposition, trial, hearing or arbitration; (b) meeting telephonically or in person with attorneys or agents designated by the Company, at a reasonable time and place designated by the Company and prior to the giving of testimony, for the purpose of discussing such testimony; and (c) providing the Company with any relevant documentation in Employee’s custody, control or possession.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences